VentriPoint Diagnostics Ltd

FRA:5V7 (Canada)  
€ 0.12 (-6.06%) Jul 18
At Loss
Market Cap:
€ 21.01M ($ 22.85M)
Enterprise V:
€ 20.99M ($ 22.84M)
Volume:
-
Avg Vol (2M):
3.89K
Trade In:

Business Description

Description
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.
Name Current Vs Industry Vs History
Cash-To-Debt 1.07
Equity-to-Asset -1.08
Debt-to-Equity -0.38
Debt-to-EBITDA -0.08
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -98.38
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -12.6
3-Year EPS without NRI Growth Rate -14.5
3-Year FCF Growth Rate -17
Name Current Vs Industry Vs History
5-Day RSI 31.59
9-Day RSI 40.33
14-Day RSI 43.65
6-1 Month Momentum % -34.87
12-1 Month Momentum % -18.06

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.42
Quick Ratio 0.42
Cash Ratio 0.25
Days Sales Outstanding 219
Days Payable 48878.71

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.3
Shareholder Yield % -0.34

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 84.44
Operating Margin % -10402.22
Net Margin % -10477.78
FCF Margin % -8387.1
ROE % -371.2
ROA % -163.79
ROIC % -1089.11
ROC (Joel Greenblatt) % -1762.16
ROCE % -292.84

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -6.77
EV-to-EBITDA -6.87
EV-to-Revenue 698.04
EV-to-FCF -8.31
Earnings Yield (Greenblatt) % -14.77
FCF Yield % -12.02

Financials

FRA:5V7's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

VentriPoint Diagnostics Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.031
EPS (TTM) (€) -0.028
Beta 2.33
Volatility % 148.66
14-Day RSI 43.65
14-Day ATR (€) 0.005629
20-Day SMA (€) 0.13175
12-1 Month Momentum % -18.06
52-Week Range (€) 0.077 - 0.24
Shares Outstanding (Mil) 157.18

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

VentriPoint Diagnostics Ltd Filings

Filing Date Document Date Form
No Filing Data

VentriPoint Diagnostics Ltd Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

VentriPoint Diagnostics Ltd Frequently Asked Questions

What is VentriPoint Diagnostics Ltd(FRA:5V7)'s stock price today?
The current price of FRA:5V7 is €0.12. The 52 week high of FRA:5V7 is €0.24 and 52 week low is €0.08.
When is next earnings date of VentriPoint Diagnostics Ltd(FRA:5V7)?
The next earnings date of VentriPoint Diagnostics Ltd(FRA:5V7) is .
Does VentriPoint Diagnostics Ltd(FRA:5V7) pay dividends? If so, how much?
VentriPoint Diagnostics Ltd(FRA:5V7) does not pay dividend.

Press Release

Subject Date
No Press Release